<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(10)</volume><submitter>Salmon DA</submitter><funding>US Centers for Disease Control and Prevention</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>In response to reports of thrombosis with thrombocytopenia syndrome (TTS) post-vaccination, the Johnson &amp; Johnson (J&amp;J) vaccine was paused and then restarted in April 2021. Our objective was to assess whether this pause adversely impacted vaccine confidence.&lt;h4>Methods&lt;/h4>Two large internet-based surveys were conducted in the US among adults to measure knowledge, attitudes and perceptions of the J&amp;J vaccine pause and rates of vaccine hesitancy among unvaccinated persons before, during and after the pause.&lt;h4>Results&lt;/h4>Among 66% of respondents aware of the pause, 44% identified blood clots as the reason for the pause without prompting. The impact of the pause on vaccine behavior among unvaccinated persons and perception of the vaccine safety system was mixed and modifi</pubmed_abstract><journal>PloS one</journal><pagination>e0274443</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9553048</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson &amp; Johnson on vaccine hesitancy and acceptance among the unvaccinated population.</pubmed_title><pmcid>PMC9553048</pmcid><pubmed_authors>Mai BS</pubmed_authors><pubmed_authors>Laurie S</pubmed_authors><pubmed_authors>Orenstein WA</pubmed_authors><pubmed_authors>Weakland LF</pubmed_authors><pubmed_authors>Harvey SA</pubmed_authors><pubmed_authors>Lavery JV</pubmed_authors><pubmed_authors>Breiman RF</pubmed_authors><pubmed_authors>Sargent RH</pubmed_authors><pubmed_authors>Schuh HB</pubmed_authors><pubmed_authors>Salmon DA</pubmed_authors><pubmed_authors>Konja A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of vaccine pause due to Thrombosis with thrombocytopenia syndrome (TTS) following vaccination with the Ad26.COV2.S vaccine manufactured by Janssen/Johnson &amp; Johnson on vaccine hesitancy and acceptance among the unvaccinated population.</name><description>&lt;h4>Background&lt;/h4>In response to reports of thrombosis with thrombocytopenia syndrome (TTS) post-vaccination, the Johnson &amp; Johnson (J&amp;J) vaccine was paused and then restarted in April 2021. Our objective was to assess whether this pause adversely impacted vaccine confidence.&lt;h4>Methods&lt;/h4>Two large internet-based surveys were conducted in the US among adults to measure knowledge, attitudes and perceptions of the J&amp;J vaccine pause and rates of vaccine hesitancy among unvaccinated persons before, during and after the pause.&lt;h4>Results&lt;/h4>Among 66% of respondents aware of the pause, 44% identified blood clots as the reason for the pause without prompting. The impact of the pause on vaccine behavior among unvaccinated persons and perception of the vaccine safety system was mixed and modifi</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-05T12:19:05.077Z</modification><creation>2025-04-05T12:19:05.077Z</creation></dates><accession>S-EPMC9553048</accession><cross_references><pubmed>36219617</pubmed><doi>10.1371/journal.pone.0274443</doi></cross_references></HashMap>